PTC Therapeutics
282
$55.709876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$55.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.24 (+2.28%) As of 2:01 PM EDT today
+$1.24 (+2.28%) Today
Why Robinhood?
You can buy or sell PTCT and other stocks, options, ETFs, and crypto commission-free!
About PTCT
PTC Therapeutics, Inc. Common Stock, also called PTC Therapeutics, is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. Read More It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
Employees
761
Headquarters
South Plainfield, New Jersey
Founded
1998
Market Cap
3.56B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
693.38K
High Today
$56.62
Low Today
$54.69
Open Price
$55.44
Volume
235.81K
52 Week High
$59.89
52 Week Low
$30.79
Collections
Analyst Ratings
70%
of 10 ratings
Buy
70%
Hold
30%
Sell
0%
PTCT Earnings
-$1.81
-$1.21
-$0.60
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 6, After Hours